Notre invité cette semaine est Dr Alexandre Bouchard. Dr Bouchard a donné en mai dernier, au congrès annuel, une conférence sur le programme québécois de dépistage du cancer colorectal (PQDCCR), qui a été déployé récemment au Québec. Nous vous offrons ici le contenu de sa présentation.
Votre hôte est Dr Jean-Pierre Gagné.
Visitez notre site internet au www.chirurgiequebec.ca
Scalpel sur le cell n’offre pas de conseils aux patients ; nous vous invitons à consulter votre médecin.

Ép 27 | Le programme québécois de dépistage du cancer colorectal (PQDCCR). Dr Alexandre Bouchard

Este é um podcast promovido pelo Grupo SOnHe, chamado Podcast Confronto, com foco em inovações e destaques de 2024 no tratamento do câncer de próstata. O episódio conta com o apoio da Bayer e está disponível na plataforma Spotify no canal do Grupo SOnHe.

Detalhes do Episódio:
Tema: "Câncer de próstata em foco: inovações e destaques de 2024"
Moderador: Dr. André Sasse (Oncologista, CRM: 91.384 | RQE: 21.423)
Debatedores:
Dr. Rafael Luís (Oncologista, CRM: 156.336 | RQE: 71.669)
Dr. Vinícius Conceição (Oncologista, CRM: 120.034 | RQE: 76.576)
O podcast explora os avanços mais recentes no diagnóstico e tratamento do câncer de próstata, destacando as perspectivas para 2024. O objetivo é informar médicos, profissionais da saúde e o público em geral sobre novidades que podem impactar positivamente os cuidados oncológicos.

Câncer de Próstata em Foco: inovações e destaques pós ESMO 2024.

BUFFALO, NY - November 25, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on November 12, 2024, entitled, “Visualizing radiological data bias through persistence images.”

This editorial highlights a powerful tool called "persistence images," which could improve how medical imaging and artificial intelligence (AI) systems are developed and used. Authors Yashbir Singh, Colleen Farrelly, Quincy A. Hathaway, and Gunnar Carlsson from the Department of Radiology, Mayo Clinic (Rochester, MN), provide a detailed explanation of how persistence images uncover hidden biases and advance fairness in healthcare AI.

AI is becoming a major part of healthcare, helping clinicians analyze X-rays, magnetic resonance imaging, and computed tomography scans. However, if the data used to train AI systems is biased, it could lead to unfair or inaccurate results. Derived from topological data analysis (TDA), persistence images transform complex medical scans into simple, stable visuals. These images make it easier to spot patterns or irregularities that could indicate bias. For example, they can reveal whether certain groups—such as patients of a specific age, gender, or ethnicity—are underrepresented in the data used to train AI systems.

“The use of persistence images in radiological analysis opens up new possibilities for identifying and addressing biases in both data interpretation and AI model training...” 

This could help ensure that AI systems work equitably for all patient groups, resulting in more reliable diagnoses and better outcomes.

In addition to detecting bias, persistence images also help filter out noise, or irrelevant details, from medical scans. This makes it easier for both AI systems and radiologists to focus on meaningful features in the images, improving overall accuracy. These insights help AI systems perform better and make more accurate, trustworthy decisions.

Despite their potential, persistence images face challenges. Generating persistence images for large datasets demands substantial computing power, while integration into clinical workflows requires user-friendly tools and specialized training for healthcare professionals.

As healthcare becomes more data-driven, tools like persistence images could transform how medical imaging is used. 

“By helping us visualize and address hidden biases, they can contribute to improved patient outcomes and more personalized healthcare delivery.”

In conclusion, this editorial envisions a future where advanced mathematical tools like persistence images play a vital role in eliminating bias and improving patient outcomes. Integrating these tools into clinical workflows could enhance radiological analysis, setting new standards for accuracy and equity in healthcare worldwide.

DOI -  https://doi.org/10.18632/oncotarget.28670

Correspondence to - Yashbir Singh - singh.yashbir@mayo.edu

Video short - https://www.youtube.com/watch?v=sQELv8oi3ew

About Oncotarget 

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:

Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh

MEDIA@IMPACTJOURNALS.COM

Oncotarget

Visualizing Radiological Data Bias with Persistence Images

Café Fm Mundo - Dr. Iván Maldonado, La Importancia De Las Mamografías

@brainworm063 basically did everything, thank you so much!!🧟‍♀️💖🔊

[@bjdripley]
g t a a spaceship, fly it straight to the pentagon 
terrorism basics, fuck d o d is what i'm on
fuck d o d is what i'm on, got to say hate racists
all i do is cry and bone, i g t a a spaceship
fly it straight to the pentagon, terrorism basics
fuck d o d is what i'm on, fuck d o d,fuck d o dfuckfuck

i kill myself so I'll kill you too bitch
that's what you get for bein useless
draugr stench leak from vents in the distance
draugr are here and death is their mission 
the draugr call from cracks in the television
the draugr have been here from the beginning 
draugr jerky skin I hunt em like venison 
a draugr is company man politician
draugr massacre gives me tunnel vision 

i made you, by workin every weekend 
i gave to you, my body all i got is addiction 

love shown to my mission is all that im wishin for 
im losin, all track of time 
I don't feel human, less im writin these lines
im fucking useless, less there's sweat in my eyes 
oh baby do this, just open your thighs

{@brainworm063}
ТВОЕ ЕБЛО СЛЕТАЕТ КОГДА Я КАТАЮ НА ДОСКЕ 
Я ОГРАБЛЮ ВЕСЬ ТВОЙ РАЗУМ ПИСТОЛЕТ В ТВОЕМ ВИСКЕ 
СВЕРХУ ВНИЗ ЗА ВАМИ НАБЛЮДАЮ МОЙ МАЧЕТЕ В РЮКЗАКЕ 
ТЕЛО ЧТО ЗАПРЯТАЛ Я ХРАНЮ В ГРУЗОВИКЕ 
 
Я ПОПАЛ В ТВОЮ БАШКУ ВОЙНУ Я НАЗЫВАЮ ВОР 
Я ЗАСТАВИЛ ЕЁ ХАВАТЬ ЧЕРВЯКОВ Я ВОЛОНТЁР 
КРОВЬ МОЧА ЕЁ СЛЕЗА КИШКИ ВЕСЯТ МОГИЛЬНЫЙ КАМЕНЬ 
Я РОЖДЕН В ЭПОХУ ЗЛА ГОРОД КИШАЩИЙ МАНЬЯКАМИ 
 
ХОЧЕШЬ ПОИГРАТЬ СО МНОЙ НО ДЛЯ МЕНЯ ЭТ НЕ ИГРА 
КОПАЕШЬ ЭТУ ЯМУ САМ НЕ ЗНАЯ ЧТО ОНА ТВОЯ 
ВОКРУГ ОБМАН ВЕЗДЕ ПИЗДЕЖ Я ОБЕЗГЛАВИЛ ЕЁ ДОЧЬ 
ЗАПОЛНИ ПУСТОТУ ВНУТРИ СЕБЯ САМ БОГ НЕ СМОГ ПОМОЧЬ

https://soundcloud.com/brainworm063 https://soundcloud.com/brainworm063 https://soundcloud.com/brainworm063 https://soundcloud.com/brainworm063

draugr|драугр [ft/prod. BRAINWORM]

As Lung Cancer Awareness Month progresses, this discussion hosted by Oncology Data Advisor sheds light on the advancements in lung cancer therapies, unmet needs, the evolving landscape of molecular testing, and actionable insights for clinicians.

Lung Cancer Awareness Month: Treatment Updates in 2024

BUFFALO, NY - November 27, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on November 12, 2024, entitled “Persistence landscapes: Charting a path to unbiased radiological interpretation.”

In this editorial, Yashbir Singh, Colleen Farrelly, Quincy A. Hathaway, and Gunnar Carlsson from the Department of Radiology, Mayo Clinic (Rochester, MN), introduce persistence landscapes, a mathematical method designed to address biases in medical imaging and artificial intelligence (AI). Persistence landscapes build on persistence images, which track how patterns in data appear and disappear across different scales. By transforming this complex data into simpler, more manageable forms, persistence landscapes create a format that is easy to analyze and compare. This makes it a valuable tool for identifying and correcting biases in medical imaging.

Medical imaging plays a critical role in healthcare, but it is not perfect. Biases, caused by differences in equipment, technology, or even the patient population, can lead to inaccurate diagnoses. Persistence landscapes offer a way to identify and fix these hidden issues. 

"[...] persistence landscapes have the potential to play a crucial role in identifying and mitigating biases in radiological practice, whether these biases stem from demographic factors, equipment variations, or the limitations of AI algorithms.”

Persistence landscapes are particularly effective at reducing random noise in medical images while preserving important details. This makes it easier for clinicians and researchers to focus on the most meaningful parts of an image. The method also improves AI tools by addressing common problems, such as when models are too focused on specific details or when they miss important information. Additionally, persistence landscapes also simplify the integration of data from different scan types, like positron emission tomography (PET) and magnetic resonance imaging (MRI), without introducing new errors.

Despite its potential, the use of persistence landscapes in real-world medical imaging comes with challenges. It requires powerful computers to process large data, which can be costly and time-consuming, and expert interpretation for meaningful use. Better tools are needed to make this method more accessible for clinicians. While integrating this method into clinical settings will take effort, the benefits could be transformative. With further research and refinement, persistence landscapes hold enormous promise for advancing equitable healthcare.

“Persistence landscapes represent a powerful new tool in our ongoing efforts to achieve unbiased and accurate radiological interpretation.”

DOI - https://doi.org/10.18632/oncotarget.28671

Correspondence to - Yashbir Singh - singh.yashbir@mayo.edu

Video short - https://www.youtube.com/watch?v=kq1pEhZvLXc

Subscribe for free publication alerts from Oncotarget: 
https://www.oncotarget.com/subscribe/

About Oncotarget 

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:

Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh

MEDIA@IMPACTJOURNALS.COM

Persistence Landscapes: A Path to Unbiased Radiological Interpretation

In this special episode of Managed Care Cast, the executive editor of The American Journal of Managed Care, Mary Caffrey, speaks with Tyler Sandahl, PharmD, of Cleveland Clinic, and Michael Byrne, DO, of Tennessee Oncology, about the use of bispecific antibodies to treat patients with multiple myeloma, the importance of caregivers for this regimen, how the entire staff plays a role, the common adverse events patients need to be looking out for, and more.

Operationalizing Bispecifics in Multiple Myeloma

soul survivor

A track i wrote when my mom was diagnosed with Cancer. Hope it helps someone.

M.I.S.S. Y.O.U.

Iconic Southern Rock brothers Donnie and Johnny Van Zant reunite as  to release their first ever Christian album sharing about their faith that has been a constant thread throughout their lives. From Johnny’s work as the lead vocalist of Lynyrd Skynyrd to Donnie’s success with 38 Special, and Ronnie's posthumous legacy with Skynyrd as a founding member, they share how they balance honoring the past with creating fresh sounds in their first ever Jesus record title "Always Look Up." The duo sits down with nine-time Emmy winner David Sams and share heart-felt stories about music, legacy, and the enduring power of family bonds. #vanzant #keepthefaith #alwayslookup #thereyouare #davidsams #contagiousinfluencer

# 264: VAN ZANT, the iconic Southern Rock duo reunite to release their first ever Jesus album and talk about family, faith & legacy

Време е за продължението на епизода ни с молекулярния генетик д-р Любомир Балабански от август, когато заявихме, че след изчерпателнo поднесената информация за това как гените влияят на дълголетието ни, ще Ви покажем и какво всъщност съдържа един генетичен тест.
Voilà, ето ги и резултатите и пълната информация, която ще получите, ако си направите такива.

Резултатите от генетичния тест не са диагноза, а важна информация, която ще Ви даде време за предотвратяването на евентуални рискове, които можете лесно да подминете с осъзната промяна в начина си на живот, целенасочена и честа профилактика и т.н. Те са и способ, с който можете да подобрите спортните си постижения, да насочите времето си в подходящите Ви таланти, да разберете защо някои медикаменти Ви действат по-добре от други, както и да опознаете предците си.

Д-р Любомир Балабански е в лаборатория Cell Genetics и Ви очаква, ако искате да се погрижите за здравето си.
https://cellgenetics.bg/za-nas/

Ако не сте гледали предния епизод с д-р Балабански, ето го и него:
https://youtu.be/oWImeuGJ2ik

Приятно гледане и слушане на епизод №3 от Reality Check сериите:

Последвай ни и в:

YouTube: https://www.youtube.com/channel/UCEm_RCjgVE91kjdyOO9_7kw/videos
Instagram: https://www.instagram.com/legends__podcast/
Twitter: https://twitter.com/LegendiLegends
Spotify: https://spoti.fi/2TeTM1p
Apple Podcasts: https://podcasts.apple.com/bg/podcast/legendi-legends/id1538275381
Google Podcasts : https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjg5NjIxNTM0OC9zb3VuZHMucnNz?sa=X&ved=2ahUKEwjg6eXspYXtAhUI9hoKHVTgAw4Q9sEGegQIARAC
SoundCloud: https://soundcloud.com/cfcjgwgp3shy
Deezer: https://www.deezer.com/us/show/2067872?deferredFl=1
-
Георги Харизанов
Веселин Вълчев

Легенди / Legends
Българският подкаст

Reality Check #3: Генетични тестове с д-р Любомир Балабански в Лаборатория Cell Genetics

Researchers at Sweden’s Karolinska Institutet have developed groundbreaking cancer-fighting nanobots that could transform cancer treatment. These tiny robots are designed to deliver more targeted and less harmful therapies than traditional treatments like chemotherapy. Equipped with a hidden “weapon” of hexagonal peptides, the nanobots remain dormant until they encounter the acidic environment typical of solid tumors. Once activated, they precisely target and destroy cancer cells, leaving healthy cells unharmed, thus reducing the side effects of conventional treatments.

The success of these nanobots lies in their ability to detect pH differences between healthy and cancerous tissues. In pre-clinical trials, the nanobots were injected into mice with breast cancer, resulting in a 70% reduction in tumor growth compared to a control group. This promising result sets the stage for further studies on their effectiveness in more advanced cancer models and their potential side effects.

Though still in the early stages, the technology represents a major step forward in personalized cancer treatment. Future research aims to improve the targeting of these nanobots by attaching proteins or peptides that can bind to specific cancer cells, making treatment even more precise. Researchers are optimistic that this innovation could pave the way for a new, more effective approach to cancer care.

What's right: Nanobots fighting cancer

En este episodio platicamos sobre:

•El gobierno de México, presenta el regreso de Jóvenes construyendo el futuro

•Lunes de Salud con el IMSS: Nos exponen su tratamiento de quimioterapia de inducción en cáncer de cavidad oral,  tumores de cabeza y cuello, tras ponencia del Dr. José Francisco Gallegos Hernández, en Francia

•Australia prohíbe el uso de las redes sociales a menores de 16 años

02 diciembre 2O24 - Cáncer de boca

This is my journey of cancer with the support of Spirit. In this episode, I talk about post chemo and also the gratitude of all the support in my life. Take a listen.

CM 97 Spirituality and Cancer Part 5 Post Chemo  29_11_2024, 1.25 am

46 år gammel får Christine diagnosen nevrofibromatose, en sykdom som gir økt risiko for å få brystkreft. Allikevel utsetter hun mammografi undersøkelsen to ganger, og tenker «det skjer ikke meg». Når hun undersøker brystene sine oppdager hun en kul, som viste seg å være brystkreft. Etter tøff behandling med cellegift og operasjoner blir Christine kreftfri. Hun tenker at livet skal bli som før, men seneffektene setter en stopper for arbeidslivet og Christine blir ufør. Det betyr ikke at hun ikke har idéer, tanker og prosjekter. I disse dager kommer hun ut med boken «Til deg med kreft» som er den boken hun selv, og hennes pårørende, hadde ønsket å få når hun selv ble kreftsyk!

Kreftkompasset episode 159

why did you die

🌟 Podcast OncoPonto: "Câncer de Pele: A Força da Multiespecialidade na Prevenção e Tratamento" 🌟

Descubra como a integração entre diferentes especialidades médicas está revolucionando a prevenção e o tratamento do câncer de pele! 💡 Neste episódio do OncoPonto, um bate-papo esclarecedor e enriquecedor com especialistas renomados:

🎙️ Moderadora:

Dra. Débora Curi – Oncologista (CRM: 173184 | RQE: 104263)
💬 Debatedores:

Dra. Rebeca Dias– Cirurgiã de cabeça e pescoço (CRM: 162676 | RQE: 79417)
Dr. Antonio Gomes Neto – Dermatologista (CRM: 115779 | RQE: 30599)
🚨 Vamos falar sobre:

A importância do diagnóstico precoce 🔍
Estratégias de prevenção que salvam vidas ☀️🧴
Tratamentos inovadores e o papel da multidisciplinaridade no cuidado ao paciente 💪
📅 Não perca essa oportunidade de se informar e cuidar melhor da sua saúde! 🩺

📌 Disponível no Spotify: Acompanhe o Grupo SOnHe e fique por dentro de temas essenciais para a oncologia e hematologia. 🎧

➡️ Juntos, podemos divulgar o câncer de pele com conhecimento e ação! 💛

Câncer de Pele: A Força da Multidiespecialidade na Prevenção e no Tratamento

curssd

Scalpel sur le cell est un balado éducatif produit par le Comité de développement professionnel continu de l’Association Québécoise de chirurgie. Le comité vous offre des capsules de formation sur différents sujets relevant de la pratique chirurgicale.

Le contenu de Scalpel sur le cell est présenté à des fins éducatives. Nous n'offrons pas de conseils spécifiques aux patients. Nous vous encourageons à contacter votre médecin.

Pour plus de détails concernant l’Association Québécoise de chirurgie et pour connaitre nos activités de développement professionnel continu, visitez notre site internet au www.chirurgiequebec.ca

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

¡TE INFORMAMOS LO BUENO, DONDE QUIERA QUE ESTES!

Some of the music i share is by ai. vocals are all done my myself.  and some of the lyrics are by chat gpt some are written by me.   I portrayed  gene simmons as a tribute artist and appeared in charity events and cancer events.i was 12 when i learned bass and then guitar.played in bands such as rock and gospel and Spanish trio.Now at 60 i decided to enjoy singing just to entertain you.its here so learn to live in it.

Europe's best independent music station based in Luxembourg! English speaking.

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.

Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/

25 99' producer/rapper ♡( ◡‿◡ ) most art by me
free based world 🪳 repost feed the algo with 💖
insta/discord/telegram: @bjdripley dms 4 collab :}
im just doin this shit for fun…φ(。。*)🔥[[̲̅$̲̅(̲̅5)̲̅$̲̅]🔥
'*•¸♡ kcmo white trash blunt smoka :) .𖥔 ݁🕷°
pfp girl by @chimii777 !!! 💖

I am an engineer turned Spiritual Medium.  Not an easy transition, but trying to figure it out to help others develop in a grounded yet limitless way.  After all, we are spiritual beings having a human experience.

Hello! I am White Elephant (Whi-El) from Western Michigan.

Българският подкаст - The Bulgarian podcast

FM Mundo te trae la mejor programación y el mejor equipo de comunicadores de la radio ecuatoriana. Producimos contenido relevante y de calidad; marcamos la pauta en noticias, actualidad y entretenimiento. Adaptándonos a nuestros selectos oyentes, diariamente compartiremos una selección de nuestros programas para que los disfruten a su conveniencia: cuando y donde prefieran. FM Mundo, informa, acompaña y entretiene.

New tracks tagged #Câncer